These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 32503434)
1. Identification of novel alternative splicing isoform biomarkers and their association with overall survival in colorectal cancer. Lian H; Wang A; Shen Y; Wang Q; Zhou Z; Zhang R; Li K; Liu C; Jia H BMC Gastroenterol; 2020 Jun; 20(1):171. PubMed ID: 32503434 [TBL] [Abstract][Full Text] [Related]
2. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data. Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491 [TBL] [Abstract][Full Text] [Related]
3. Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response. Xiao Y; Gao L; Zhao X; Zhao W; Mai L; Ma C; Han Y; Li X Int Immunopharmacol; 2024 Sep; 139():112603. PubMed ID: 39043103 [TBL] [Abstract][Full Text] [Related]
4. Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer. Wang C; Weng M; Xia S; Zhang M; Chen C; Tang J; Huang D; Yu H; Sun W; Zhang H; Lai M Cancer Sci; 2021 Jan; 112(1):178-193. PubMed ID: 33058325 [TBL] [Abstract][Full Text] [Related]
6. The Identification of Prognostic and Metastatic Alternative Splicing in Skin Cutaneous Melanoma. Huang R; Li M; Zeng Z; Zhang J; Song D; Hu P; Yan P; Xian S; Zhu X; Chang Z; Zhang J; Guo J; Yin H; Meng T; Huang Z Cancer Control; 2022; 29():10732748211051554. PubMed ID: 34986671 [TBL] [Abstract][Full Text] [Related]
7. Deciphering alternative splicing events and their therapeutic implications in colorectal Cancer. Ding W; Xiao Q; Yue Y; Chen S; She X; Pan B; Zhou L; Yin Y; Li Y; Wang S; Xu M Cell Signal; 2024 Jun; 118():111134. PubMed ID: 38484942 [TBL] [Abstract][Full Text] [Related]
8. Role of COL6A3 in colorectal cancer. Liu W; Li L; Ye H; Tao H; He H Oncol Rep; 2018 Jun; 39(6):2527-2536. PubMed ID: 29620224 [TBL] [Abstract][Full Text] [Related]
9. RNA processing genes characterize RNA splicing and further stratify colorectal cancer. Lu X; Zhou Y; Meng J; Jiang L; Gao J; Cheng Y; Yan H; Wang Y; Zhang B; Li X; Yan F Cell Prolif; 2020 Aug; 53(8):e12861. PubMed ID: 32596958 [TBL] [Abstract][Full Text] [Related]
10. Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer. Arafat H; Lazar M; Salem K; Chipitsyna G; Gong Q; Pan TC; Zhang RZ; Yeo CJ; Chu ML Surgery; 2011 Aug; 150(2):306-15. PubMed ID: 21719059 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel alternative splicing biomarkers for breast cancer with LC/MS/MS and RNA-Seq. Zhang F; Deng CK; Wang M; Deng B; Barber R; Huang G BMC Bioinformatics; 2020 Dec; 21(Suppl 9):541. PubMed ID: 33272210 [TBL] [Abstract][Full Text] [Related]
12. Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome. Zhang J; Deng Y; Zuo Y; Wang J; Zhao Y DNA Cell Biol; 2020 Jan; 39(1):16-24. PubMed ID: 31808724 [TBL] [Abstract][Full Text] [Related]
13. Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics. Qiao J; Fang CY; Chen SX; Wang XQ; Cui SJ; Liu XH; Jiang YH; Wang J; Zhang Y; Yang PY; Liu F Oncotarget; 2015 Oct; 6(30):29929-46. PubMed ID: 26338966 [TBL] [Abstract][Full Text] [Related]
14. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer. Gao X; Yang J DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181 [TBL] [Abstract][Full Text] [Related]
15. An isoform-resolution transcriptomic atlas of colorectal cancer from long-read single-cell sequencing. Li Z; Zhang B; Chan JJ; Tabatabaeian H; Tong QY; Chew XH; Fan X; Driguez P; Chan C; Cheong F; Wang S; Siew BE; Tan IJ; Lee KY; Lieske B; Cheong WK; Kappei D; Tan KK; Gao X; Tay Y Cell Genom; 2024 Sep; 4(9):100641. PubMed ID: 39216476 [TBL] [Abstract][Full Text] [Related]
16. Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer. Sun Q; Han Y; He J; Wang J; Ma X; Ning Q; Zhao Q; Jin Q; Yang L; Li S; Li Y; Zhi Q; Zheng J; Dong D Genome Med; 2023 Sep; 15(1):76. PubMed ID: 37735421 [TBL] [Abstract][Full Text] [Related]
17. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer. Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070 [TBL] [Abstract][Full Text] [Related]
18. Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer. Pan YJ; Huo FC; Kang MJ; Liu BW; Wu MD; Pei DS Clin Transl Med; 2022 Nov; 12(11):e1113. PubMed ID: 36394206 [TBL] [Abstract][Full Text] [Related]
19. Alternative splicing: An important regulatory mechanism in colorectal carcinoma. Wang J; Wang C; Li L; Yang L; Wang S; Ning X; Gao S; Ren L; Chaulagain A; Tang J; Wang T Mol Carcinog; 2021 Apr; 60(4):279-293. PubMed ID: 33629774 [TBL] [Abstract][Full Text] [Related]
20. Alternative Splicing Events as Indicators for the Prognosis of Uveal Melanoma. Wan Q; Sang X; Jin L; Wang Z Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32098099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]